Comparison of oral Betahistine and intramuscular promethazine in treatment of acute peripheral vertigo in emergency department
Phase 2
- Conditions
- Acute peripheral vertigo.Diseases of the ear and mastoid process
- Registration Number
- IRCT2015062022834N1
- Lead Sponsor
- Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
patients aged 18-65 years old with peripheral acute vertigo. Exclusion criteria: contraindications of promethazin and betahistine; pregnant and breast feeding women; central vertigo.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptom control. Timepoint: 0, 1, 2 and 4 hours after treatment. Method of measurement: VAG score.
- Secondary Outcome Measures
Name Time Method Occurance of drug side effects. Timepoint: During the first 4 hours. Method of measurement: Monitoring the patient.